The role of the cGMP-PKG pathway in retinal degeneration has been extensively studied (85, 86, 87), and pharmacological inhibition of excessive cGMP activity protects the retinas in rd1, rd2, and rd10 RP mouse models (48). Here, PRPH2 is linked to retinal degeneration.